Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.
Investor's Business Daily on MSN
Travere crashed into its 200-day line and then reversed higher; here's why
Shares of Travere Therapeutics took a hit Tuesday, but closed in the green, after fewer than expected patients started taking ...
Q3 earnings swing to loss as revenue rises Travere Therapeutics (TVTX) just delivered third quarter 2026 numbers that pulled investor attention to both sides of the income statement. Revenue reached ...
Travere Therapeutics has delivered a very large 3 year share price gain, which naturally puts the spotlight on whether the ...
Management reiterated the long-term FILSPARI goal rather than issuing quarterly EPS or revenue guidance: Dr. Dube said results and demand trends “are aligned with our long-term goals of achieving $3 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Travere Therapeutics, Inc. (TVTX) on Monday reported a loss of $52.3 million in its third ...
Travere Therapeutics stock falls 2.2% to $49.26 today after the latest financial results and leadership update.
Revenue reached $224.6 million versus $164.9 million a year earlier. HARMONY topline results are anticipated in the second half of 2027.
Reports Q3 revenue $224.6M, consensus $195.3M. “Strong execution across our business drove another quarter of significant ...
U.S. net product sales for the third quarter of 2026 were $220.2 million, compared to $113.2 million for the same period in ...
Revenue went the other way. It reached $224.56 million, beating the $192.52 million consensus by 16.6% and growing 36.2% year over year. FILSPARI net sales crossed $200 million for the first time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results